Ascites News and Research

RSS
Commercial implants of ALFApump System for refractory ascites performed at Vienna General Hospital

Commercial implants of ALFApump System for refractory ascites performed at Vienna General Hospital

Sarcoma Oncology Center, Aethlon Medical to study ex vivo effectiveness of Hemopurifier

Sarcoma Oncology Center, Aethlon Medical to study ex vivo effectiveness of Hemopurifier

Measures to reduce BMI could improve outcome for patients with cirrhosis

Measures to reduce BMI could improve outcome for patients with cirrhosis

Sequana Medical's ALFApump System for liver cirrhosis receives CE Mark approval

Sequana Medical's ALFApump System for liver cirrhosis receives CE Mark approval

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Trifunctional antibody Catumaxomab triggers vaccination effect against cancer

Trifunctional antibody Catumaxomab triggers vaccination effect against cancer

NovaShunt launches new corporate identity and product branding

NovaShunt launches new corporate identity and product branding

Enrollment commences in Gore Early TIPS study for ascites at Indiana University Hospital

Enrollment commences in Gore Early TIPS study for ascites at Indiana University Hospital

Salix Pharmaceuticals receives three U.S. patents relating to rifaximin

Salix Pharmaceuticals receives three U.S. patents relating to rifaximin

NovaShunt raises Series B financing for CHF 23.7 million

NovaShunt raises Series B financing for CHF 23.7 million

Magnetic nanoparticles for ovarian cancer treatment

Magnetic nanoparticles for ovarian cancer treatment

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Gore announces new Early TIPS for Ascites Study

Gore announces new Early TIPS for Ascites Study

Salix to discuss XIFAXAN therapy for hepatic encephalopathy at AASLD 2010 Annual Meeting

Salix to discuss XIFAXAN therapy for hepatic encephalopathy at AASLD 2010 Annual Meeting

Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets

Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets

Recommendations available for managing ascites, SBP and hepatorenal syndrome

Recommendations available for managing ascites, SBP and hepatorenal syndrome

Novel molecular pathway that regulates invasive growth, metastasis in ER-positive breast cancer discovered

Novel molecular pathway that regulates invasive growth, metastasis in ER-positive breast cancer discovered

Presence and type of cirrhosis complications are strong predictors of mortality: Study

Presence and type of cirrhosis complications are strong predictors of mortality: Study

Stress hormones may suppress tumor growth: Study

Stress hormones may suppress tumor growth: Study

NovaShunt initiates study to evaluate AFS for refractory ascites patients

NovaShunt initiates study to evaluate AFS for refractory ascites patients